Hippocratic AI, a healthcare startup specializing in AI tools for non-diagnostic patient care tasks, has raised $141 million in a Series B funding round, boosting its valuation to $1.64 billion. Led by Kleiner Perkins, the funding builds on previous investments from General Catalyst, Andreessen Horowitz, and NVIDIA. Founded less than two years ago, Hippocratic AI focuses on addressing the healthcare workforce shortage by creating AI agents capable of handling tasks like preoperative procedures, remote monitoring, and appointment preparation.
Unlike most generative AI companies that emphasize reducing administrative workloads, Hippocratic AI centers its efforts on direct patient support. In 2024, the company secured contracts with 23 health systems and insurers, showcasing strong market adoption. The newly raised capital will enable the company to expand its products into additional markets and pursue international growth, furthering its mission to enhance healthcare accessibility and efficiency through advanced AI solutions.